Ahmed Ahmed E, Abo El-Magd Essam A, Hasan Gamal M, El-Asheer Osama M
Pediatric Department, Qena University Hospital, Faculty of Medicine, South Valley University, Qena, Egypt.
Otorhinolaryngology Department, Aswan University Hospital, Faculty of Medicine, Aswan University, Aswan, Egypt.
Adolesc Health Med Ther. 2015 Sep 30;6:165-70. doi: 10.2147/AHMT.S84806. eCollection 2015.
Epistaxis is a common medical problem in pediatric population. Although in most cases it is mild and self-limiting, a proportion of childhood epistaxis is massive, recurrent, or resistant to conventional management.
To compare effectiveness of propranolol as a treatment option for childhood epistaxis versus conventional silver nitrate cautery.
This is a prospective interventional comparative study that was carried out during a period of 1 year (January 1, 2013 to December 31, 2013) at Qena University Hospital and Assiut University Children's Hospital. One hundred children aged 6-12 years who presented with epistaxis to Qena University Hospital and Assiut University Children's Hospital during the study period and fulfilling the inclusion criteria were included in the study. They were randomly assigned into one of two interventional groups, where 50 children were treated with oral propranolol (propranolol treatment group) and another 50 children were treated with conventional silver nitrate cautery (cauterization treatment group) for their epistaxis. Propranolol was given at a dose of 1.5-2 mg/kg/day (divided into three doses). Patients were followed for 6 months after their discharge for recurrence of epistaxis.
Both groups of patients showed minimal recurrent epistaxis with rates of 14% for propranolol treated group and 12% for cauterization group, with no statistically significant difference between both groups. Local pain was found to be more in patients treated with silver nitrate cauterization.
Treatment of primary epistaxis with propranolol or silver nitrate cautery showed equal rates of recurrence, and local nasal pain was slightly more among silver nitrate cauterization treated group. Propranolol could be a favorable treatment option for patients with primary epistaxis. Further studies that include multiple centers and larger number of patients are recommended for more clarification of the effectiveness of such treatment option.
鼻出血是儿科人群中常见的医学问题。虽然在大多数情况下症状较轻且具有自限性,但一部分儿童鼻出血较为严重、反复发作或对传统治疗方法无效。
比较普萘洛尔与传统硝酸银烧灼术治疗儿童鼻出血的效果。
这是一项前瞻性干预性对比研究,于2013年1月1日至2013年12月31日在基纳大学医院和阿斯尤特大学儿童医院进行了为期1年的研究。在研究期间,100名年龄在6至12岁、因鼻出血到基纳大学医院和阿斯尤特大学儿童医院就诊且符合纳入标准的儿童被纳入研究。他们被随机分为两个干预组,其中50名儿童接受口服普萘洛尔治疗(普萘洛尔治疗组),另外50名儿童接受传统硝酸银烧灼术治疗(烧灼治疗组)以治疗鼻出血。普萘洛尔的给药剂量为1.5 - 2毫克/千克/天(分三次给药)。患者出院后随访6个月,观察鼻出血复发情况。
两组患者鼻出血复发率均较低,普萘洛尔治疗组为14%,烧灼治疗组为12%,两组之间无统计学显著差异。发现硝酸银烧灼术治疗的患者局部疼痛更明显。
用普萘洛尔或硝酸银烧灼术治疗原发性鼻出血的复发率相同,硝酸银烧灼术治疗组的局部鼻痛略多。普萘洛尔可能是原发性鼻出血患者的一种良好治疗选择。建议开展包括多个中心和更多患者的进一步研究,以更明确这种治疗选择的有效性。